Search Results - "Visseren, Frank L."

Perivascular adipose tissue as a cause of atherosclerosis by Verhagen, Sandra N, Visseren, Frank L.J

“…Abstract Perivascular adipose tissue surrounds (coronary) arteries and may be involved in local stimulation of atherosclerotic plaque formation. Epicardial…”
Get full text

Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials by de Jong, Marit, van der Worp, H Bart, van der Graaf, Yolanda, Visseren, Frank L J, Westerink, Jan

“…Pioglitazone targets multiple pathogenic pathways involved in the development of cardiovascular diseases (CVD). The aim of this systematic review and…”
Get full text

Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions by Biessels, Geert Jan, Prof, Strachan, Mark W J, Prof, Visseren, Frank L J, Prof, Kappelle, L Jaap, Prof, Whitmer, Rachel A, PhD

“…Summary Type 2 diabetes is associated with dementia, and also with more slight cognitive decrements. In this Review we discuss trajectories from normal…”
Get full text

Adipose tissue dysfunction in obesity, diabetes, and vascular diseases by Hajer, Gideon R., van Haeften, Timon W., Visseren, Frank L.J.

“…The classical perception of adipose tissue as a storage place of fatty acids has been replaced over the last years by the notion that adipose tissue has a…”
Get full text

Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes by Sharif, Shahnam, Van der Graaf, Y, Cramer, M J, Kapelle, L J, de Borst, G J, Visseren, Frank L J, Westerink, Jan

“…Type 2 diabetes is a condition associated with a state of low-grade inflammation caused by adipose tissue dysfunction and insulin resistance. High…”
Get full text

Obesity and Cancer: The Role of Dysfunctional Adipose Tissue by VAN KRUIJSDIJK, Rob C. M, VAN DER WALL, Elsken, VISSEREN, Frank L. J

“…Overweight and obesity are health problems of epidemic proportions, increasing the risk not only of cardiovascular disease and type 2 diabetes mellitus but…”
Get full text

Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol by Ray, Kausik K, Landmesser, Ulf, Leiter, Lawrence A, Kallend, David, Dufour, Robert, Karakas, Mahir, Hall, Tim, Troquay, Roland P.T, Turner, Traci, Visseren, Frank L.J, Wijngaard, Peter, Wright, R. Scott, Kastelein, John J.P

“…Inclisiran, a small interfering RNA that targets PCSK9 mRNA, was given as a single injection at baseline or in two doses at baseline and 90 days. At 180 days,…”
Get full text

Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia by Kastelein, John J.P, Akdim, Fatima, Stroes, Erik S.G, Zwinderman, Aeilko H, Bots, Michiel L, Stalenhoef, Anton F.H, Visseren, Frank L.J, Sijbrands, Eric J.G, Trip, Mieke D, Stein, Evan A, Gaudet, Daniel, Duivenvoorden, Raphael, Veltri, Enrico P, Marais, A. David, de Groot, Eric

“…In a 2-year clinical trial, the addition of ezetimibe to simvastatin had no effect on the progression of atherosclerosis, as measured by carotid-artery…”
Get full text

Association of body mass index and waist circumference with long-term mortality risk in 10,370 coronary patients and potential modification by lifestyle and health determinants by Cruijsen, Esther, Bonekamp, Nadia E, Koopal, Charlotte, Winkels, Renate M, Visseren, Frank L J, Geleijnse, Johanna M

“…Body adiposity is known to affect mortality risk in patients with coronary artery disease (CAD). We examined associations of body mass index (BMI) and waist…”
Get full text

Allopurinol to reduce cardiovascular morbidity and mortality: A systematic review and meta-analysis by van der Pol, Karel H, Wever, Kimberley E, Verbakel, Mariette, Visseren, Frank L J, Cornel, Jan H, Rongen, Gerard A

“…To compare the effectiveness of allopurinol with no treatment or placebo for the prevention of cardiovascular events in hyperuricemic patients. Pubmed, Web of…”
Get full text

Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis by Jancev, Milena, Vissers, Tessa A. C. M., Visseren, Frank L. J., van Bon, Arianne C., Serné, Erik H., DeVries, J. Hans, de Valk, Harold W., van Sloten, Thomas T.

“…Aims/hypothesis Continuous glucose monitoring (CGM) is increasingly used in the treatment of type 2 diabetes, but the effects on glycaemic control are unclear…”
Get full text

Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score by de Winter, Maria A, Büller, Harry R, Carrier, Marc, Cohen, Alexander T, Hansen, John-Bjarne, Kaasjager, Karin A H, Kakkar, Ajay K, Middeldorp, Saskia, Raskob, Gary E, Sørensen, Henrik T, Visseren, Frank L J, Wells, Philip S, Dorresteijn, Jannick A N, Nijkeuter, Mathilde

“…Abstract Aims Deciding to stop or continue anticoagulation for venous thromboembolism (VTE) after initial treatment is challenging, as individual risks of…”
Get full text

Modifiable risk factors in adults with and without prior cardiovascular disease: findings from the Indonesian National Basic Health Research by Arsyad, Dian Sidik, Westerink, Jan, Cramer, Maarten J, Ansar, Jumriani, Wahiduddin, Visseren, Frank L J, Doevendans, Pieter A, Ansariadi

“…The majority of risk factors for cardiovascular diseases (CVDs) are modifiable. Continuous monitoring and control of these factors could significantly reduce…”
Get full text

Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP by Matsushita, Kunihiro, Kaptoge, Stephen, Hageman, Steven H J, Sang, Yingying, Ballew, Shoshana H, Grams, Morgan E, Surapaneni, Aditya, Sun, Luanluan, Arnlov, Johan, Bozic, Milica, Brenner, Hermann, Brunskill, Nigel J, Chang, Alex R, Chinnadurai, Rajkumar, Cirillo, Massimo, Correa, Adolfo, Ebert, Natalie, Eckardt, Kai-Uwe, Gansevoort, Ron T, Gutierrez, Orlando, Hadaegh, Farzad, He, Jiang, Hwang, Shih-Jen, Jafar, Tazeen H, Jassal, Simerjot K, Kayama, Takamasa, Kovesdy, Csaba P, Landman, Gijs W, Levey, Andrew S, Lloyd-Jones, Donald M, Major, Rupert W, Miura, Katsuyuki, Muntner, Paul, Nadkarni, Girish N, Nowak, Christoph, Ohkubo, Takayoshi, Pena, Michelle J, Polkinghorne, Kevan R, Sairenchi, Toshimi, Schaeffner, Elke, Schneider, Markus P, Shalev, Varda, Shlipak, Michael G, Solbu, Marit D, Stempniewicz, Nikita, Tollitt, James, Valdivielso, José M, van der Leeuw, Joep, Wang, Angela Yee-Moon, Wen, Chi-Pang, Woodward, Mark, Yamagishi, Kazumasa, Yatsuya, Hiroshi, Zhang, Luxia, Dorresteijn, Jannick A N, Di Angelantonio, Emanuele, Visseren, Frank L J, Pennells, Lisa, Coresh, Josef

“…The 2021 European Society of Cardiology (ESC) guideline on cardiovascular disease (CVD) prevention categorizes moderate and severe chronic kidney disease (CKD)…”
Get full text

Hypertension and longitudinal changes in cerebral blood flow: The SMART-MR study by Muller, Majon, van der Graaf, Yolanda, Visseren, Frank L., Mali, Willem P. Th. M., Geerlings, Mirjam I.

“…Objective: Cerebral hypoperfusion is among the mechanisms that may explain the association of high blood pressure (BP) with dementia. However, few data are…”
Get full text

Population median imputation was noninferior to complex approaches for imputing missing values in cardiovascular prediction models in clinical practice by Berkelmans, Gijs F.N., Read, Stephanie H., Gudbjörnsdottir, Soffia, Wild, Sarah H., Franzen, Stefan, van der Graaf, Yolanda, Eliasson, Björn, Visseren, Frank L.J., Paynter, Nina P., Dorresteijn, Jannick A.N.

“…To compare the validity and robustness of five methods for handling missing characteristics when using cardiovascular disease risk prediction models for…”
Get full text

The relation between urinary sodium and potassium excretion and risk of cardiovascular events and mortality in patients with cardiovascular disease by Groenland, Eline H, Vendeville, Jean-Paul, Bots, Michiel L, de Borst, Gert Jan, Nathoe, Hendrik M, Ruigrok, Ynte M, Blankestijn, Peter J, Visseren, Frank L J, Spiering, Wilko

“…Most evidence on the relationship between sodium and potassium intake and cardiovascular disease originated from general population studies. This study aimed…”
Get full text

Asymptomatic Carotid Artery Stenosis and the Risk of Ischemic Stroke According to Subtype in Patients With Clinical Manifest Arterial Disease by DEN HARTOG, Anne G, ACHTERBERG, Sefanja, MOLL, Frans L, JAAP KAPPELLE, L, VISSEREN, Frank L. J, VAN DER GRAAF, Yolanda, ALGRA, Ale, DE BORST, Gert Jan

“…Because best medical treatment is improving, the risk of stroke in asymptomatic carotid artery stenosis (ACAS) may decline. We evaluated the risk of ischemic…”
Get full text

The readiness of public primary health care (PUSKESMAS) for cardiovascular services in Makasar city, Indonesia by Arsyad, Dian Sidik, Hamsyah, Esliana Fitrida, Qalby, Nurul, Qanitha, Andriany, Westerink, Jan, Cramer, Maarten J, Visseren, Frank L J, Doevendans, Pieter A, Ansariadi, Ansariadi

“…The increasing burden of cardiovascular disease (CVD) has become a major challenge globally, including in Indonesia. Understanding the readiness of primary…”
Get full text

Screen-detected abnormal ankle brachial index: A risk indicator for future cardiovascular morbidity and mortality in patients with manifest cardiovascular disease by Jagt, Vivianne L, Hazenberg, Constantijn E V B, Kapelle, Jaap, Cramer, Maarten J, Visseren, Frank L J, Westerink, Jan

“…The ankle brachial index (ABI) can be used to diagnose peripheral arterial disease (PAD). The clinical relevance of the ABI, especially in patients with known…”
Get full text